Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

NCT00148109 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Cetuximab
DRUG: Cetuximab

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]